bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of bluebird bio Inc..
bluebird bio Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of bluebird bio Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of bluebird bio Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of bluebird bio Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of bluebird bio Inc. and all latest updates of the company are provided.
The 2025 version of bluebird bio Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 bluebird bio Inc.- Key Facts
2.2 bluebird bio Inc.- Geographic Locations
2.3 bluebird bio Inc.- Subsidiaries and Affiliates
2.4 bluebird bio Inc.- Business Divisions
2.5 bluebird bio Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. bluebird bio Inc. Strategic Analysis Review
3.1 bluebird bio Inc.- Key Strategies
3.2 bluebird bio Inc.- Company Outlook Statement
3.3 bluebird bio Inc.- SWOT Analysis
3.3.1 bluebird bio Inc.- Key Strengths
3.3.2 bluebird bio Inc.- Key Weaknesses
3.3.3 bluebird bio Inc.- Potential Opportunities
3.3.4 bluebird bio Inc.- Potential Threats
3.4 bluebird bio Inc.- Key Competitors
4. Business Description of the Company
4.1 bluebird bio Inc.- Business Overview
4.2 bluebird bio Inc.- Operations by Segment
5 Products and Services Details
5.1 bluebird bio Inc.- Key Products
5.2 bluebird bio Inc.- Key Service Areas
5.3 bluebird bio Inc.- Key Brands
6 Company Developments
6.1 bluebird bio Inc.- Company History
6.2 bluebird bio Inc.- Latest Developments
7 Financial Analysis
7.1 bluebird bio Inc.- Income Statements
7.2 bluebird bio Inc.- Balance Sheet
7.3 bluebird bio Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 bluebird bio Inc.- Direct Competitors
8.2 bluebird bio Inc.- Competitor Financial Ratios comparison
8.3 bluebird bio Inc.- Competitor Stock Charts Comparison
8.4 bluebird bio Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!